Recurrent Disease Recruiting Phase 1 Trials for Methotrexate (DB00563)

IndicationStatusPhase
DBCOND0028541 (Recurrent Disease)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03792256Palbociclib in Combination With Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LL)Treatment